Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$209.01 - $232.56 $180,166 - $200,466
862 Added 10.68%
8,931 $1.95 Million
Q4 2023

Feb 09, 2024

SELL
$197.69 - $227.29 $39,142 - $45,003
-198 Reduced 2.4%
8,069 $1.83 Million
Q3 2023

Oct 24, 2023

BUY
$201.05 - $221.7 $60,918 - $67,175
303 Added 3.8%
8,267 $1.66 Million
Q2 2023

Jul 13, 2023

SELL
$211.93 - $241.33 $36,875 - $41,991
-174 Reduced 2.14%
7,964 $1.92 Million
Q1 2023

May 11, 2023

SELL
$213.32 - $257.83 $220,572 - $266,596
-1,034 Reduced 11.27%
8,138 $1.87 Million
Q4 2022

Feb 08, 2023

SELL
$203.72 - $248.97 $120,805 - $147,639
-593 Reduced 6.07%
9,172 $2.16 Million
Q3 2022

Oct 17, 2022

SELL
$204.81 - $262.19 $2.74 Million - $3.51 Million
-13,402 Reduced 57.85%
9,765 $2 Million
Q2 2022

Jul 13, 2022

BUY
$213.86 - $277.87 $2.89 Million - $3.75 Million
13,494 Added 139.5%
23,167 $5.43 Million
Q1 2022

May 12, 2022

SELL
$259.82 - $298.18 $261,638 - $300,267
-1,007 Reduced 9.43%
9,673 $2.55 Million
Q4 2021

Feb 03, 2022

SELL
$271.6 - $314.21 $238,193 - $275,562
-877 Reduced 7.59%
10,680 $3.36 Million
Q3 2021

Nov 02, 2021

BUY
$274.82 - $308.34 $319,890 - $358,907
1,164 Added 11.2%
11,557 $3.25 Million
Q2 2021

Aug 10, 2021

SELL
$251.87 - $278.14 $79,842 - $88,170
-317 Reduced 2.96%
10,393 $2.87 Million
Q1 2021

May 07, 2021

BUY
$204.88 - $255.03 $57,366 - $71,408
280 Added 2.68%
10,710 $2.73 Million
Q4 2020

Feb 04, 2021

SELL
$186.91 - $214.42 $468,583 - $537,550
-2,507 Reduced 19.38%
10,430 $2.12 Million
Q3 2020

Oct 29, 2020

BUY
$167.03 - $201.3 $138,300 - $166,676
828 Added 6.84%
12,937 $2.44 Million
Q2 2020

Jul 27, 2020

BUY
$113.31 - $182.44 $405,876 - $653,500
3,582 Added 42.01%
12,109 $2.01 Million
Q1 2020

May 08, 2020

SELL
$104.32 - $195.28 $120,176 - $224,962
-1,152 Reduced 11.9%
8,527 $1.08 Million
Q4 2019

Feb 04, 2020

BUY
$163.48 - $173.61 $276,117 - $293,227
1,689 Added 21.14%
9,679 $1.64 Million
Q3 2019

Nov 06, 2019

SELL
$159.77 - $178.1 $32,113 - $35,798
-201 Reduced 2.45%
7,990 $1.34 Million
Q2 2019

Aug 15, 2019

BUY
$144.16 - $172.9 $52,474 - $62,935
364 Added 4.65%
8,191 $0
Q1 2019

May 08, 2019

BUY
$123.7 - $156.3 $9,153 - $11,566
74 Added 0.95%
7,827 $0
Q4 2018

Feb 05, 2019

BUY
$120.82 - $174.09 $400,880 - $577,630
3,318 Added 74.81%
7,753 $979,000
Q3 2018

Nov 02, 2018

BUY
$167.67 - $188.27 $19,952 - $22,404
119 Added 2.76%
4,435 $0
Q2 2018

Aug 10, 2018

BUY
$160.33 - $189.41 $10,742 - $12,690
67 Added 1.58%
4,316 $0
Q1 2018

May 09, 2018

BUY
$161.53 - $178.11 $28,267 - $31,169
175 Added 4.3%
4,249 $0
Q4 2017

Feb 22, 2018

BUY
$147.99 - $163.95 $30,485 - $33,773
206 Added 5.33%
4,074 $0
Q3 2017

Nov 07, 2017

BUY
$149.47 - $160.56 $17,637 - $18,946
118 Added 3.15%
3,868 $584,000
Q2 2017

Aug 08, 2017

BUY
N/A
3,750
3,750 $578,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.